{
    "2020-08-23": [
        [
            {
                "time": "",
                "original_text": "累计亏损扩大至4.70亿元，但扩张步伐仍将狂奔，疫苗“后浪”康希诺能否卡到C位？ 亏损",
                "features": {
                    "keywords": [
                        "累计亏损",
                        "扩张步伐",
                        "疫苗",
                        "康希诺"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "太平洋医药行业周报：新冠为检测行业带来的不止业绩 还有渗透率提升",
                "features": {
                    "keywords": [
                        "太平洋医药",
                        "新冠",
                        "检测行业",
                        "业绩",
                        "渗透率提升"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "检测行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}